Clinical Trial Update: Effects of Niacin on Intramyocellular Fatty Acid Trafficking in Upper Body Obesity and Type 2 Diabetes Mellitus [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial from Mayo Clinic assessed the effects of niacin on intramyocellular fatty acid trafficking in individuals with upper body obesity and typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Niacin (nicotinic acid)

Snippet

Sponsor: Mayo Clinic | Conditions: Type 2 Diabetes Mellitus, Obesity | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-08-06